{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:18:37Z","timestamp":1791757117051,"version":"4.3.4"},"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2314-B-038-024"],"award-info":[{"award-number":["NSTC 113-2314-B-038-024"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018493","name":"Taipei Medical University-Shuang Ho Hospital, Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["113FRP-20"],"award-info":[{"award-number":["113FRP-20"]}],"id":[{"id":"10.13039\/100018493","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008903","name":"Ministry of Health and Welfare","doi-asserted-by":"publisher","award":["MOHW110-TDU-B-212-124004"],"award-info":[{"award-number":["MOHW110-TDU-B-212-124004"]}],"id":[{"id":"10.13039\/100008903","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The American Heart Association recently issued guidelines introducing the concept of cardiovascular\u2013kidney\u2013metabolic (CKM) syndrome to emphasize the importance of multidisciplinary approaches to prevention, risk stratification, and treatment for these diseases. This study assessed the prevalence of CKM syndrome stages and the mortality risk associated with its components in a large Asian cohort.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      We analyzed a retrospective cohort of 515,602 participants aged \u226520 years from a health screening program conducted between 1996 and 2017 in Taiwan. We assessed the associations of all-cause mortality, cardiovascular disease (CVD) mortality, and cause-specific mortality with CKM stages and its components\u2014hypertension, diabetes mellitus, chronic kidney disease (CKD), metabolic syndrome, and hyperlipidemia. All participants were followed for a median of 16.5 years (interquartile range: 11.5, 21.2 years). Multivariate Cox proportional hazards models, adjusted for age, sex, educational level, smoking status, alcohol drinking status, and physical activity groups, were used to calculate hazard ratios (HRs). We used Chiang\u2019s life table method to estimate years of life lost due to each CKM component. Among all participants, 257,535 (49.9%) were female. The majority of participants (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009368,578 participants, (71.5%)) met criteria for CKM syndrome, with prevalence rates of 19.5%, 46.3%, 1.9%, and 3.8% for stages 1, 2, 3, and 4, respectively. CKM syndrome was associated with higher risks of all-cause mortality (HR: 1.33; 95% confidence interval, CI: 1.28, 1.39), CVD mortality (HR: 2.81; 95% CI: 2.45, 3.22), and incident end-stage kidney disease (ESKD) (HR: 10.15; 95% CI: 7.54, 13.67). Each additional CKM component was associated with a 22% increase in the risk of all-cause mortality (HR: 1.22; 95% CI: 1.21, 1.23), a 37% increase in the risk of CVD mortality (HR: 1.37; 95% CI: 1.35, 1.40) compared with those without any CKM components. In addition, each additional component reduced average life expectancy by 3 years. The population-attributable fractions of CKM syndrome were 18.7% (95% CI: 15.8, 21.7) for all-cause mortality and 55.0% (95% CI: 49.0, 60.4) for CVD mortality. We estimated that failing to include CKD in CKM syndrome could result in the missed attribution of 11% of CVD deaths. The primary limitation is that our analysis relied on baseline measurements only, without accounting for longitudinal changes.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In the large cohort study, the prevalence of CKM syndrome and its components were associated with risks of all-cause mortality, CVD mortality, and ESKD. These findings highlight the clinical need for integrated care within CKM health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004629","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T13:44:27Z","timestamp":1750945467000},"page":"e1004629","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":73,"title":["Cardiovascular\u2013kidney\u2013metabolic syndrome and all-cause and cardiovascular mortality: A retrospective cohort study"],"prefix":"10.1371","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2528-3911","authenticated-orcid":true,"given":"Min-Kuang","family":"Tsai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Tze-Wah","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Shun","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Te","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4818-8263","authenticated-orcid":true,"given":"Wei-Cheng","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4979-8351","authenticated-orcid":true,"given":"Kuo-Liong","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi-Pang","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai-Szu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5777-2752","authenticated-orcid":true,"given":"Mei-Yi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"issue":"25","key":"pmed.1004629.ref001","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.jacc.2023.11.007","article-title":"Global burden of cardiovascular diseases and risks, 1990-2022","volume":"82","author":"Global Burden of Cardiovascular Diseases and Risks Collaborators","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"25","key":"pmed.1004629.ref002","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.jacc.2022.11.005","article-title":"The global burden of cardiovascular diseases and risk: a compass for future health","volume":"80","author":"M Vaduganathan","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"pmed.1004629.ref003","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.kint.2019.07.012","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"96","author":"KJ Jager","year":"2019","journal-title":"Kidney International"},{"issue":"9981","key":"pmed.1004629.ref004","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"T Liyanage","year":"2015","journal-title":"Lancet"},{"issue":"10397","key":"pmed.1004629.ref005","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"GBD 2021 Diabetes Collaborators","year":"2023","journal-title":"Lancet"},{"issue":"10225","key":"pmed.1004629.ref006","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","journal-title":"Lancet"},{"issue":"9455","key":"pmed.1004629.ref007","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)17741-1","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"PM Kearney","year":"2005","journal-title":"Lancet"},{"issue":"20","key":"pmed.1004629.ref008","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"CE Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"20","key":"pmed.1004629.ref009","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of Cardiovascular-Kidney-Metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"CE Ndumele","year":"2023","journal-title":"Circulation"},{"issue":"11","key":"pmed.1004629.ref010","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.120.007264","article-title":"Cardio-renal-metabolic care models: toward achieving effective interdisciplinary care","volume":"13","author":"J Rangaswami","year":"2020","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"16","key":"pmed.1004629.ref011","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000664","article-title":"Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement From the American Heart Association","volume":"139","author":"J Rangaswami","year":"2019","journal-title":"Circulation"},{"issue":"1","key":"pmed.1004629.ref012","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio-renal-metabolic connection: a review of the evidence","volume":"22","author":"M Marassi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"pmed.1004629.ref013","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1111\/dom.14829","article-title":"Interconnection between cardiovascular, renal and metabolic disorders: a narrative review with a focus on Japan","volume":"24","author":"T Kadowaki","year":"2022","journal-title":"Diabetes Obes Metab"},{"issue":"7","key":"pmed.1004629.ref014","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"A Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"pmed.1004629.ref015","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41581-025-00928-3","article-title":"Approaches to raise awareness of CKD among patients and the general population","volume":"21","author":"DS Tuot","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"pmed.1004629.ref016","article-title":"KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease","volume":"98","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Diabetes Work Group","year":"2020","journal-title":"Kidney Int"},{"issue":"2","key":"pmed.1004629.ref017","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"DK McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"issue":"6","key":"pmed.1004629.ref018","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1056\/NEJMcibr2409089","article-title":"Discovery of GLP-1-based drugs for the treatment of obesity","volume":"392","author":"DJ Drucker","year":"2025","journal-title":"N Engl J Med"},{"issue":"24","key":"pmed.1004629.ref019","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"B Pitt","year":"2021","journal-title":"N Engl J Med"},{"issue":"9631","key":"pmed.1004629.ref020","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1016\/S0140-6736(08)60952-6","article-title":"All-cause mortality attributable to chronic kidney disease: a prospective cohort study based on 462 293 adults in Taiwan","volume":"371","author":"CP Wen","year":"2008","journal-title":"Lancet"},{"issue":"9798","key":"pmed.1004629.ref021","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/S0140-6736(11)60749-6","article-title":"Minimum amount of physical activity for reduced mortality and extended life expectancy: a prospective cohort study","volume":"378","author":"CP Wen","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"pmed.1004629.ref022","article-title":"Cohort profile: the Taiwan MJ Cohort: half a million Chinese with repeated health surveillance data","volume":"46","author":"X Wu","year":"2017","journal-title":"Int J Epidemiol"},{"key":"pmed.1004629.ref023","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1161\/CIR.0000000000001191","article-title":"Novel prediction equations for absolute risk assessment of total cardiovascular disease incorporating cardiovascular-kidney-metabolic health: a scientific statement from the American Heart Association","volume":"148","author":"SS Khan","year":"2023","journal-title":"Circulation"},{"key":"pmed.1004629.ref024","article-title":"Development and validation of the American Heart Association predicting risk of cardiovascular disease EVENTs (PREVENT) equations","author":"SS Khan","year":"2023","journal-title":"Circulation"},{"issue":"18","key":"pmed.1004629.ref025","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jama.2012.3954","article-title":"Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate","volume":"307","author":"K Matsushita","year":"2012","journal-title":"JAMA"},{"issue":"4","key":"pmed.1004629.ref026","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/1741826710389422","article-title":"Attributable mortality burden of metabolic syndrome: comparison with its individual components","volume":"18","author":"CP Wen","year":"2011","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"5","key":"pmed.1004629.ref027","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.mayocp.2021.10.027","article-title":"Role of physical activity in lowering risk of end-stage renal disease","volume":"97","author":"MK Tsai","year":"2022","journal-title":"Mayo Clin Proc"},{"issue":"17","key":"pmed.1004629.ref028","doi-asserted-by":"crossref","first-page":"21513","DOI":"10.18632\/aging.203491","article-title":"Converting health risks into loss of life years - a paradigm shift in clinical risk communication","volume":"13","author":"SP Tsai","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"pmed.1004629.ref029","first-page":"221","article-title":"A stochastic study of the life table and its applications. II. Sample variance of the observed expectation of life and other biometric functions","volume":"32","author":"CL Chiang","year":"1960","journal-title":"Hum Biol"},{"issue":"1","key":"pmed.1004629.ref030","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001160","article-title":"Adult mortality attributable to preventable risk factors for non-communicable diseases and injuries in Japan: a comparative risk assessment","volume":"9","author":"N Ikeda","year":"2012","journal-title":"PLoS Med"},{"issue":"18","key":"pmed.1004629.ref031","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.jacc.2024.03.368","article-title":"Prevalence of the cardiovascular-kidney-metabolic syndrome in the United States","volume":"83","author":"AMK Minhas","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"pmed.1004629.ref032","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1186\/s12889-023-15768-8","article-title":"Multimorbidity and social determinants of health in the US prior to the COVID-19 pandemic and implications for health outcomes: a cross-sectional analysis based on NHANES 2017-2018","volume":"23","author":"B Mossadeghi","year":"2023","journal-title":"BMC Public Health"},{"issue":"11","key":"pmed.1004629.ref033","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jamacardio.2023.3241","article-title":"Prevalence and overlap of cardiac, renal, and metabolic conditions in US adults, 1999-2020","volume":"8","author":"JW Ostrominski","year":"2023","journal-title":"JAMA Cardiol"},{"issue":"5","key":"pmed.1004629.ref034","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41581-024-00812-6","article-title":"A united vision for cardiovascular-kidney-metabolic health","volume":"20","author":"SE Quaggin","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"pmed.1004629.ref035","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2004030203","article-title":"Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999","volume":"16","author":"RN Foley","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"pmed.1004629.ref036","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000536038","article-title":"Mortality and renal outcomes are impacted by obesity in cardiorenal metabolic disease but not in people with concomitant diabetes mellitus","volume":"14","author":"S Al-Chalabi","year":"2024","journal-title":"Cardiorenal Med"},{"issue":"1","key":"pmed.1004629.ref037","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/s12882-022-02966-6","article-title":"Cardiovascular events and mortality in chronic kidney disease in primary care patients with previous type 2 diabetes and\/or hypertension. A population-based epidemiological study (KIDNEES)","volume":"23","author":"O Cunillera-Pu\u00e9rtolas","year":"2022","journal-title":"BMC Nephrol"},{"key":"pmed.1004629.ref038","doi-asserted-by":"crossref","first-page":"3964013","DOI":"10.1155\/2021\/3964013","article-title":"The impact of new-onset diabetes mellitus and hypertension on all-cause mortality in an apparently healthy population: a ten-year follow-up study","volume":"2021","author":"S Charoensri","year":"2021","journal-title":"J Diabetes Res"},{"issue":"6","key":"pmed.1004629.ref039","doi-asserted-by":"crossref","first-page":"323","DOI":"10.21037\/atm.2020.02.144","article-title":"Prehypertension and risk for all-cause and cardiovascular mortality by diabetes status: results from the national health and nutrition examination surveys","volume":"8","author":"YQ Huang","year":"2020","journal-title":"Ann Transl Med"},{"issue":"21","key":"pmed.1004629.ref040","doi-asserted-by":"crossref","first-page":"6868","DOI":"10.3390\/jcm12216868","article-title":"Management of hypertension in diabetic kidney disease","volume":"12","author":"GB Colbert","year":"2023","journal-title":"J Clin Med"},{"issue":"1","key":"pmed.1004629.ref041","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1161\/HYPERTENSIONAHA.114.04334","article-title":"Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study","volume":"65","author":"N Bansal","year":"2015","journal-title":"Hypertension"},{"key":"pmed.1004629.ref042","doi-asserted-by":"crossref","first-page":"1185707","DOI":"10.3389\/fcvm.2023.1185707","article-title":"Cardiorenal syndrome and diabetes: an evil pairing","volume":"10","author":"AB M\u00e9ndez Fern\u00e1ndez","year":"2023","journal-title":"Front Cardiovasc Med"},{"issue":"9889","key":"pmed.1004629.ref043","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0140-6736(13)60595-4","article-title":"Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention","volume":"382","author":"RT Gansevoort","year":"2013","journal-title":"Lancet"},{"issue":"10","key":"pmed.1004629.ref044","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1001\/jamainternmed.2021.4823","article-title":"Overdiagnosis of chronic kidney disease in older adults-an inconvenient truth","volume":"181","author":"AM O\u2019Hare","year":"2021","journal-title":"JAMA Intern Med"},{"issue":"10","key":"pmed.1004629.ref045","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1093\/ckj\/sfac119","article-title":"A prediction model with lifestyle factors improves the predictive ability for renal replacement therapy: a cohort of 442\u2009714 Asian adults","volume":"15","author":"MK Tsai","year":"2022","journal-title":"Clin Kidney J"},{"key":"pmed.1004629.ref046","article-title":"Cardiovascular-kidney-metabolic health syndrome: what does the American Heart Association framework mean for nephrology?","author":"N Bansal","year":"2024","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"pmed.1004629.ref047","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.healthpol.2017.10.002","article-title":"Managing multimorbidity: profiles of integrated care approaches targeting people with multiple chronic conditions in Europe","volume":"122","author":"M Rijken","year":"2018","journal-title":"Health Policy"}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004629","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T13:44:58Z","timestamp":1750945498000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004629"}},"subtitle":[],"editor":[{"given":"David","family":"Flood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":47,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,6,26]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004629","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]}}}